THE DEAL, AT A GLANCE
From the announcementAlector
01Who is involvedBacked by VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedAlector raised $176M Series DFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersAlector's Series D financing supports an AI immuno-neurology strategy focused on Alzheimer's and FTD, with capital directed to advancing AL001 and AL101 through Phase 3…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Alector · Financing Record
Explore source-linked visual explanations for Alector. Unsupported claims are withheld while source review continues.
Record 944 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →